Company Earnings Update 3 minutesRegister for Free AccessLoblaw (TSX: L) 4Q18 Results: Revenues Miss Expectations as Food Demand Proves “Moderate” and Pharmacy Sales Remain Soft Coresight Research February 22, 2019 Executive Summary Loblaw reported food retail same-store sales growth of 0.8% in 4Q18, versus 0.9% growth in the prior quarter. It reported drug retail same-store sales growth of 1.9% versus 2.5% growth the prior quarter. Total revenues of C$11.2 billion came in below the consensus estimate of C$11.27 billion recorded by StreetAccount. In FY19, the company expects to report positive same-store sales and a stable gross margin in its retail segment. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: Introducing the New “Tech 25”: Retail-Tech Companies To Watch in 2024 and Beyond—InfographicWeekly US and UK Store Openings and Closures Tracker 2024, Week 10: Rite Aid (US) and The Body Shop (UK) Confirm Further Store ClosuresUS Consumer Tracker: Avoidance Rises and Activity SlidesAnalyst Corner—AgeTech: Revolutionizing Aging in the US with Madhav Pitaliya